RyboDyn Inc.

📍 San Diego, United States🗓 Founded 2022👥 14 employees💰 Last funded Oct 2024
Biotechnology Research🌐 rybodyn.com
Website LinkedIn
RyboDyn, Inc. is targeting the dark proteome to make new immunotherapies. We are unlocking and validating previously undiscovered, disease-specific targets that will impact the treatment of cancer and autoimmune diseases by driving a new wave of targeted therapeutics. Our "targets-to-assets" therapeutics development program is supported by a scalable, in-house platform for lead discovery and optimization. We aim to deliver first-in-class assets that recognize these targets for treating solid tumors and diseases lacking effective treatment options.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2022
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in RyboDyn Inc.?
RyboDyn Inc. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did RyboDyn Inc. last raise funding?
The most recent investment in RyboDyn Inc. recorded on gritt.io was in October 2024.
When was RyboDyn Inc. founded?
RyboDyn Inc. was founded in 2022.
What industry is RyboDyn Inc. in?
RyboDyn Inc. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is RyboDyn Inc. based?
RyboDyn Inc. is headquartered in San Diego, United States.